Top compounds associated with response to RWDD4


Feature Type Standardized
Nominal ANOVA
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.6
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA SR8278 CTRPv2 pan-cancer AAC -0.059 0.6
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV